Contribution of the functional imaging in the radiotherapy treatment planning for malignant glioma: Revision of the literature  by Santoro, M. et al.
position N-3 of the adenine, whose damages are mended then by
enzymes of the family of the PARP. The latter two are repaired by
enzymes in the base excision pathway, which can be inhibited by
PARP inhibitors (Fig. 2).
At present, are ongoing clinical trials using MGMT or PARP
inhibitors to overcome the TMZ resistance.6
The TMZ, in preclinical data, shows an additive effect with the
radiation.7
In conclusion, in the treatment of glioblastoma, further stud-
ies are need to the purpose to integrate basic research and clinical
practice.
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CONTRIBUTION OF THE FUNCTIONAL IMAGING IN THE RADIO-
THERAPY TREATMENT PLANNING FOR MALIGNANT GLIOMA:
REVISION OF THE LITERATURE
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and Radiobiology, Hospital Pugliese-Ciaccio, Catanzaro, Italy
Currently, despite the efforts to improve the standard treat-
ment [surgery, radiotherapy (RT) and chemotherapy], the median
survival of patients with glioblastoma (GBM) is poor and almost of
patients die for local recurrence, both to the inside and to the out-
side of the tumoural bed. In consideration of the disappointing
gotten results, the question that emerges if it is possible to
improve radiotherapy planning integrating of new imaging tech-
niques. To the moment the standard is the use of the imaging
CT and Magnetic Resonance Imaging (MRI)-based, but for
instance MRI is not able to differentiate residual tumour and
post-operating modifications. In addition to the anatomic and
morphological findings available with con conventional imaging
methods, advanced MRI and Nuclear Medicine (NM) techniques
can give information on the metabolism of malignant glioma
cells. In this study we have analysed the following methodic of
functional imaging: 123I-alpha-methil-tyrosine-single photon
emission CT (IMT-SPECT), single-voxel proton magnetic reso-
nance spectroscopy (1H-MRS), functional MRI, diffusion tensor
imaging (DFI), [F-18]-fluorodeoxyglucose positron tomography
(18FDG-PET) and L-(methyl-11C)-labelled methionine positron
emissions tomography (MET-PET), to the purpose to integrate
her in the target delineation and in radiation dose escalation.
Every of the new techniques show potentiality and limits. For
instance, in comparison with 1H-MRS, 123I-IMT-SPECT introduces
best results in to distinguish amongst recurrent and/or residual
tumour from the post-operative changes and can be useful in
the definition of the volume target with greater accuracy and in
consideration of ‘the high specificity of the IMT uptake for the tumour
tissue, the findings on IMT-SPECT may significantly modify the target
volumes for radiotherapy planning. This will help to focus the high irra-
diation dose on the tumour area and to spare normal brain tissue’.1 The
1H-MRSI showing a high specificity and sensibility in to distin-
guish between therapy-related effects and relapse, it finds her
application in the assessment of probability of response or failure
to the treatment. Since, radiation dose escalation in malignant
glioma may lead to an increase of the disease control, the
18FDG-PET may be of great utility in to define the regions for
which to plan to radiation dose boost. The assessment of diffu-
sion properties may add information, during the follow-up, in to
distinguish between recurrence and radiation effects. In post-
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Fig. 2. Image reported from Metha MP, X Congresso Nazionale e Corso Residenziale dell’Associazione Italiana di Neuro-
Oncologia, Napoli 7–9 Novembre 2005.
E J C S U P P L E M E N T S 6 ( 2 0 0 8 ) 1 3 6 –1 3 8 137
operative setting the MET-PET showing a greater specificity for
the tumoural tissue can help in to delineate the GTV with great
accuracy. In conclusion the use of the new functional imaging
techniques in association and complementarily to the conven-
tional images, CT and MRI, he will be able in a next future to
improve the results in the care of the malignant gliomas and
the relationship efficacy and toxicity in the radiotherapy
treatment.
Reference:
1. Sundgren PC et al. IJROBP 2002;1;54 (3): 842–54.
doi:10.1016/j.ejcsup.2008.06.070
138 E J C S U P P L E M E N T S 6 ( 2 0 0 8 ) 1 3 6 –1 3 8
